Cumulative sickness absence in work days ‐ long‐term · workers on sick leave
1 finding from 1 review
Cumulative sickness absence in work days ‐ very long‐term · workers on sick leave
1 finding from 1 review
Long‐term mortality · people with hereditary haemochromatosis
1 finding from 1 review
no estimate extracted
1 participants
GRADE not reported
Pain: long‐term · people with low back pain
It is very uncertain whether back School changes pain: long‐term compared with medical care (very low certainty).
1 finding from 1 review
Disability: long‐term · people with low back pain
It is very uncertain whether back School changes disability: long‐term compared with medical care (very low certainty).
1 finding from 1 review
pain ‐ long‐term · people with low back pain
It is very uncertain whether back School changes pain ‐ long‐term compared with passive physiotherapy (very low certainty).
1 finding from 1 review
Disability ‐ long‐term · people with low back pain
It is very uncertain whether back School changes disability ‐ long‐term compared with passive physiotherapy (very low certainty).
1 finding from 1 review
Pain: long‐term · people with low back pain
Back School showed no clear difference in pain: long‐term compared with exercise (low certainty).
1 finding from 1 review
Disability: long‐term · people with low back pain
It is very uncertain whether back School changes disability: long‐term compared with exercise (very low certainty).
1 finding from 1 review
Pain: long‐term · people with low back pain
It is very uncertain whether back School changes pain: long‐term compared with no treatment (very low certainty).
1 finding from 1 review
Disability: long‐term · people with low back pain
It is very uncertain whether back School changes disability: long‐term compared with no treatment (very low certainty).
1 finding from 1 review
Incidence of serious adverse events (we used the NIH definition of adverse events. A serious event includes death, a life‐threatening event that requires hospitalization or prolonged hospitalization, disability or congenital anomaly) · peripheral nerve block
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of serious adverse events (we used the NIH definition of adverse events. A serious event includes death, a life‐threatening event that requires hospitalization or prolonged hospitalization, disability or congenital anomaly) · participants undergoing surgery with peripheral nerve block
1 finding from 1 review
Incidence of serious adverse events (we used the NIH definition of adverse events. A serious event includes death, a life‐threatening event that requires hospitalization or prolonged hospitalization, disability or congenital anomaly) · participants undergoing surgery with peripheral nerve block
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Long‐term all‐cause mortality (≥ 1 year after the intervention) · people with STEMI and MVD.
It is very uncertain whether complete revascularisation changes long‐term all‐cause mortality (≥ 1 year after the intervention) compared with culprit‐only revascularisation (very low certainty).
1 finding from 1 review
Cardiovascular mortality · people with STEMI and MVD.
It is very uncertain whether complete revascularisation changes long‐term cardiovascular mortality (≥ 1 year after the intervention) compared with culprit‐only revascularisation (very low certainty).
1 finding from 1 review
Myocardial infarction · people with STEMI and MVD.
It is very uncertain whether complete revascularisation changes long‐term myocardial infarction (≥ 1 year after the intervention) compared with culprit‐only revascularisation (very low certainty).
1 finding from 1 review
Overall adverse events (pooled short and long term) · people with STEMI and MVD.
It is very uncertain whether complete revascularisation changes overall adverse events (pooled short and long term) compared with culprit‐only revascularisation (very low certainty).
1 finding from 1 review
Long‐term revascularisation (≥ 1 year after the intervention) · people with STEMI and MVD.
It is very uncertain whether complete revascularisation changes long‐term revascularisation (≥ 1 year after the intervention) compared with culprit‐only revascularisation (very low certainty).
1 finding from 1 review
Economic outcomes: Costs due to treatment, as defined by each study (long term) · patients with schizophrenia
1 finding from 1 review